A more precise approach (IMAGE)
Caption
Michael Halassa (left), a physician-scientist and professor at the Fralin Biomedical Research Institute at VTC, with Stephen Brannan, who led the clinical development of Cobenfy, the first new approach to treating schizophrenia in decades.
Credit
Photo courtesy of Michael Halassa for Virginia Tech.
Usage Restrictions
For use with accompanying news
License
Original content